Product Images Sorafenib
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Sorafenib NDC 24979-715 by Twi Pharmaceuticals Usa, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image description - Label 120s
fig 1 - fig1
This is a comparison of the efficacy of Sorafenib versus Placebo in patients. The study involved a total of 602 patients, with 299 patients receiving Sorafenib and 303 receiving Placebo. The median time for survival in the Sorafenib group was 10.7 months, while the median time for survival in the Placebo group was 7.9 months, with a hazard ratio of 0.69 and p-value of 0.00058. The graph shows the number of patients at risk over the course of the study, which lasted up to 18 months.*
Fig 3 - fig3
image description - label 60s
image description - logo1
Structural formula - structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.